 |
|
|
| |
Scaling up HCV-DAA treatment in patients on opioid substitution therapy - does alcohol or cannabis consumption diminish cure rates? Data from the German Hepatitis C Registry (DHC-R)
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Stefan Christensen1, Peter Buggisch2, Stefan Mauss3, Klaus H. W. Böker4, Tobias Müller5, Hartwig Klinker6, Tim Zimmermann7, Yvonne Serfert8, Bernd Weber9, Jens Reimer10, Heiner Wedemeyer8,11,12, German Hepatitis C-Registry8
1CIM Münster, Münster, Germany; 2ifi-institute for interdisciplinary medicine, Hamburg, Germany; 3Center for HIV and Hepatogastroenterology, Duesseldorf, Germany; 4Hepatologische Praxis, Hannover, Germany ; 5Charité Campus Virchow-Klinikum (CVK), Berlin, Germany; 6University Hospital Würzburg, Würzburg, Germany; 7University Hospital Mainz, Mainz, Germany; 8Leberstiftungs-GmbH Deutschland; 9Praxiszentrum Friedrichsplatz / Competence Center Addiction, Kassel, Germany; 10Gesundheit Nord - Bremen Hospital Group, Bremen, Germany; 11Hannover Medical School, Hannover, Germany; 12Essen University Hospital, University of Duisburg-Essen, Essen
|
| |
|
|
|
|
|
